Co-founders and research partners
The true sign of gifted scientists is that they always have more questions than answers. Professor Meir Shinitzky, the world-renowned brain researcher who had an insatiable thirst for knowledge, was this kind of visionary biophysicist. Among his prolific research in neurology, psychology, cancer, immune systems and heredity, Shinitzky worked to crack the code on the connection between the structure of our cells and the function of these microscopic units that number in the trillions in our bodies. Shinitzky had burning questions about our cell’s gatekeepers, the membranes surrounding our cells. Shinitzky, among others, observed that there were direct links between the health of our membranes and our memory, ability to solve problems, emotions and other core life skills. Shinitzky’s journey of a lifetime delved into our cells’ building blocks. He discovered how to fuel brain and nerve cells so we can be better at what we do. Lipogen is the brainchild of Shinitzky’s fact-finding mission. Shinitzky wrote over 200 scientific journal articles, published over a half-dozen books and registered dozens of scientific patents. He shared his award-winning insights with others as a professor at the Weizmann Institute of Science and as a visiting professor at Duke University, and lectured for decades at industry forums, too many to count. Shinitzky’s protégés continue to solve his unanswered mysteries, and are posing new questions that deliver the latest insights on improving our brain health so we can each reach optimal performance.
Having had a hand in founding Lipogen as well as other start-ups, Dr. Avner Sheinfeld is a serial entrepreneur specializing in scientific and medical technologies. He is intrigued by the cell membrane’s role in human function, including memory, cognition, addiction and weight loss. Dr. Sheinfeld founded Modus, which developed a product for smoking cessation, and Linx, a pioneering solution for weight loss. The underlying technologies of these products were based on cell membrane discoveries. More recently, Dr. Sheinfeld founded Pharma Vision Design for slow release of medications to treat eye conditions. Sheinfeld is a graduate of the Weizmann Institute of Science, where he completed his doctorate in the field of cell biophysics. He holds several patents related to cell membrane innovations.
Dr. Juliane Hellhammer is the CEO of Daacro GmbH & Co. KG, a leading, full-service contract research organization that performs research for pharmaceutical and dietary supplement companies from throughout the world. Dr. Hellhammer takes special interest in health, cognitive function, disease prevention, aging, mental health, sports and women’s health issues. She is intrigued by stress – measuring it, minimizing it and protecting against it with nutritional supplements and treatments. Dr. Hellhammer directs the daacro Saliva Lab and daacro Study Site, which perform research, clinical trials and studies. She also serves as a consultant in her areas of expertise. Prior to founding daacro, Dr. Hellhammer was a research assistant at the University of Trier and the Executive Director of the Research Center for Psychobiology and Psychosomatics, a major scientific research facility operated by the University of Trier. Dr. Hellhammer has published dozens of research studies in peer-reviewed journals. She earned her PhD in psychobiology.
As a passionate food engineer, Hagit Lichtig Koren wears two hats. In one role, she’s like your favorite chemistry teacher, meticulously tinkering until she reaches product nutritional perfection, and conducting experiments – all in pursuit of the ideal supplement. On the other hand, she’s like that strict teacher who never let you get away with anything – in Lipogen’s case, obsessively auditing processes, checking ingredients, and testing final products before they leave the plant, making sure that safety and quality always come first. Hagit keeps the Lipogen plants in top compliance, setting guidelines and directing auditing for ISO, GMP (good manufacturing practices) and HACCP (Hazard Analysis and Critical Control Points) for food safety. She has a well-rounded portfolio of experience, having worked for Israel’s largest food manufacturer, a major juice producer, a biotech start-up, an engineering firm and a nutritional supplement company. Hagit earned her MSc in quality assurance and reliability and her BSc in food engineering and biotechnology. Her work keeps her on the go, as does her favorite hobby – long-distance running.
Dr. Mualem is an invaluable member of the Lipogen team, consulting on chemistry, product development processes, pharmaceuticals and biotechnology. He provides due diligence, legal opinions and patent portfolio management, assisting will just about every stage of product development and roll-out. Dr. Mualem is an expert in American regulations and has extensive knowledge of the European Patent Convention (EPC) and the range of laws and practices among European national systems. When he is not advising Lipogen, he supports leading biotech and pharma companies in Europe and the United States. Dr. Mualem earned his PhD in physics from the University of New York at Stony Brook, his LLB law degree from the University of Strasbourg – Center for Intellectual Property Studies (CEIPI) and his Master’s degree in technology management from Polytechnic University. He also holds a bachelor’s degree in chemistry and sciences from Rensselaer Polytechnic Institute. Dr. Mualem’s flawless reputation precedes him.
Prof. Yaakov Gindin is a world-renowned specialist in geriatric medicine, sharing his time as a clinician, lecturer and researcher among several medical institutions. He is the head of Geriatric Services of the Assuta Medical Centers of Israel and the Director of the Center for Standards in Health and Disability in the Research Authority of Haifa University. For two decades, Prof. Gindin was the Director of the Geriatric Institute for Education and Research at Kaplan Medical Center and of the Geriatrics Department in the Hartzfeld Geriatric Hospital. Prof. Gindin teaches in the master’s program in gerontology for medical doctors at the Faculty of Health and Social Sciences at Haifa University. Gindin was awarded grants from the Camp David Institute of International Health in 1978 and 1987, and has been a visiting assistant professor at the Albert Einstein College of Medicine in New York City since 1989. He is a fellow with InterRAI, which develops methods for treating the disabled and individuals with complex medical conditions, and is currently serving as the Chair of its International Development Committee. He has published over 30 articles on geriatric medicine and other medical topics.